The drug is a generic version of the well-known brand Vasotec and will be available in 2.5mg, 5mg, 10mg, and 20mg tablet strengths. Sunshine Biopharma plans to distribute it in Canada through its wholly-owned subsidiary, Nora Pharma Inc., with the first products expected to arrive at retail pharmacies by the end of 2026.